Upon entering the circulation, LPS first targets the liver and induces the overexpression of tumor necrosis factor-alpha (TNF-α) and chemokines, which in turn promote neutrophil infiltration, hepatocellular injury, and hepatic steatosis. The gene discussed is TNF; the disease is fatty liver disease.